Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion

MLA

Scott A Scarneo, et al. “Genetic and Pharmacological Validation of TAK1 Inhibition in Macrophages as a Therapeutic Strategy to Effectively Inhibit TNF Secretion.” The Journal of Immunology, vol. 202, May 2019, p. 68.19. EBSCOhost, https://doi.org/10.4049/jimmunol.202.supp.68.19.

APA

Scott A Scarneo, Liesl Eibschutz, Phillip Hughes, & Timothy Haystead. (2019). Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion. The Journal of Immunology, 202, 68.19. https://doi.org/10.4049/jimmunol.202.supp.68.19

Chicago

Scott A Scarneo, Liesl Eibschutz, Phillip Hughes, and Timothy Haystead. 2019. “Genetic and Pharmacological Validation of TAK1 Inhibition in Macrophages as a Therapeutic Strategy to Effectively Inhibit TNF Secretion.” The Journal of Immunology 202 (May): 68.19. doi:10.4049/jimmunol.202.supp.68.19.